We can speculate that early production of cardiac-specific IgG3 would initiate damage at the valve leading to pronounced inflammation with edema of the valve leaflets that in turn may be replaced by a sustained IgG2 deposition and concomitant cellular infiltration with IFN-γ and IL-17A directing inflammation that characterizes RHD. Here, IGHG3 is linked to rheumatic heart disease.